7HN-11814-95239
4 vaccinations
6 coded responses
49 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 274 / NC
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discomfort — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Marked discomfort in injection site shoulderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-07-12
- 2021-10-11
-
2021-12-20
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-12-23
- 2021-12-24
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2022-01-03
- 2022-01-10
-
2022-01-17
Survey response — day 28, dose 3MedDRA: Pain, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Significant worsening of CHRONIC knee & lower leg pain, and gradually worsening rotator cuff & deltoid area pain -- note that this is in OPPOSITE arm of both covid & flu injections, and each began prior to receiving them.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-24
- 2022-01-31
- 2022-03-21
- 2022-06-20
-
2022-07-27
Dose 4 — Pfizer-BioNTech
- 2022-07-27
- 2022-07-28
- 2022-07-29
- 2022-07-30
- 2022-07-31
- 2022-08-01
- 2022-08-02
- 2022-08-03
-
2022-08-10
Survey response — day 14, dose 4MedDRA: Condition aggravated, Fatigue, Headache, Poor quality sleep, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Persistent frontal headache (3 days); more easily fatigued than usual (2 days); & poor sleep (exacerbation of preexisting restless leg syndrome)MedDRA releases: 2024-11 · check-in free text available
- 2022-08-17
- 2022-08-24
-
2022-08-31
Survey response — day 35, dose 4MedDRA: Blood pressure diastolic increased, Blood pressure systolic increased, Headache — Feeling: FairFree text: Unexplained and significant elevation of systolic & diastolic BP x3 days with headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-09-08
-
2022-10-26
Survey response — 3 months, dose 4MedDRA: Asthenia, Condition aggravated, Disturbance in attention, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More easily fatigued & m7ch less stamina x few weeks; hard(er) to stay on task & concentrate than baseline (have significant ADHD)MedDRA releases: 2024-11 · check-in free text available
-
2023-01-27
Survey response — 6 months, dose 4MedDRA: Abdominal pain upper, Cough, Malaise, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-12-20 | Pfizer-BioNTech | Flu |
| 4 | 2022-07-27 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Marked discomfort in injection site shoulder
Release 10 — day 28, dose 3
Symptoms: Significant worsening of CHRONIC knee & lower leg pain, and gradually worsening rotator cuff & deltoid area pain -- note that this is in OPPOSITE arm of both covid & flu injections, and each began prior to receiving them.
Release 12 — day 14, dose 4
Symptoms: Persistent frontal headache (3 days); more easily fatigued than usual (2 days); & poor sleep (exacerbation of preexisting restless leg syndrome)
Release 12 — day 35, dose 4
Symptoms: Unexplained and significant elevation of systolic & diastolic BP x3 days with headache
Release 12 — 3 months, dose 4
Symptoms: More easily fatigued & m7ch less stamina x few weeks; hard(er) to stay on task & concentrate than baseline (have significant ADHD)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Blood pressure diastolic increased | · | · | ✓ |
| SD | Blood pressure systolic increased | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Poor quality sleep | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release